Montfort is among 80 Israeli MedTech companies to take up the figh against COVID-19: https://www.forbes.com/sites/startupnationcentral/2020/03/30/israeli-medtech-startups-fight-covid19-coronavirus/amp/
Read More...
EnchepaLog is used for Multiple Sclerosis evaluation at Tel Aviv Sourasky Medical Center – Ichilov Hospital
Read More...
We are pleased to announce a new addition to our advisory board- professor Friedemann Paul of Charité Universitätsmedizin Berlin, Germany. Prof. Paul is a professor of Clinical Neuroimmunology and head of the neuroimmunology outpatient clinic at the Experimental and Clinical Research Centre. He co-chairs Charité’s Clinical and Experimental Multiple Sclerosis (MS) Research Centre. His main
Read More...
Proud to be on NLV’s first round of investment. We appreciate your confidence. https://lnkd.in/edX-U7Q
Read More...
Montfort Brain Monitor is the winner of Henry Ford Health System’s artificial intelligence challenge in Israel. The startup was chosen from a pool of over 50 applicants and will receive clinical and research assistance of up to $75,000, as well as business and regulatory guidance tailored to the U.S. healthcare market. Here is a
Read More...
Winner of Teva’s Rise Challenge for digital health: https://lnkd.in/gVqFM9C
Read More...
Montfort completes raising a total of half a million USD, half of it from the Israeli Innovation Authority, and half from private investors. This is a good opportunity to thank all for their support and trust!
Read More...
In the last couple of months: Montfort completes raising 250,000 USD in seed round from private investors. Montfort obtains “New Companies” grant, our third program with the Israeli Innovation Authority. Montfort recognized as an R&D company under the “Angel Law”.
Read More...